About: Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1995 (uk) article scientifique publié en 1995 (fr) im Mai 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1995 (ast) scientific article published on 01 May 1995 (en)
publication date	wds:Q56945551-29EF2A8C-A0F6-4148-94A1-9450709733A7
publication date	1995-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56945551-9532FE92-3E94-4030-B334-D24898010A53
language of work or name	English
cites work	wds:Q56945551-1D8CA125-657A-4049-B7C8-C741F1EBE60C wds:Q56945551-210B0CE4-5E36-4955-8EDC-E3C638E6EC0F wds:Q56945551-2612B8B1-9AD0-4759-AF78-5A858E305D64 wds:Q56945551-274D04FD-DFF9-4E4F-A7CA-5C7407D08132 wds:Q56945551-34CA43BC-D2B0-4890-96D0-9B0FBD094A31 wds:Q56945551-3BC8681E-5078-4D2A-8641-9C888EB41A38 wds:Q56945551-455CD736-E5FC-4F1A-BEC0-148A531A16C5 wds:Q56945551-83248CC5-3A3D-4E4C-A9EC-16505B9FF5C9 wds:Q56945551-864857A3-B73A-4042-AE72-806C1D612C63 wds:Q56945551-9FB3C441-FEF7-4861-9682-E84B7595EF45 wds:Q56945551-A7ECAD6A-90E0-4F5E-A9CC-43C41E493788 wds:Q56945551-A8849999-1F04-4679-AEE8-0E07BE233205 wds:Q56945551-B5E78873-8FB4-4C41-A9BD-FBB650C00850 wds:Q56945551-D8E59BD1-C950-4EE5-BEEC-BE318EB9F073 wds:Q56945551-E39223FF-AD5C-4A02-9571-E97F29DC2216 wds:Q56945551-E98B3F68-8752-430E-BBD0-21D43EF1D805 wds:Q56945551-EF22620F-26EB-4DE7-895B-2D2C4564FCEF wds:Q56945551-F0A48200-6303-435C-9A75-83AD39EEED2B
cites work	Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction Advantages and applications of the centerline method for characterizing regional ventricular function Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group The use of single plane angiocardiograms for the calculation of left ventricular volume in man Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction Results of high dose intravenous urokinase for acute myocardial infarction
author name string	wds:Q56945551-02AC585F-35C2-4A47-B826-BE6F543C6847 wds:Q56945551-13FC9137-7047-4C6F-8F0A-1CABD498C290 wds:Q56945551-43595AD3-EBE5-41FC-8A10-451A368323D4 wds:Q56945551-A512E0D9-0839-4E65-BDF9-B9C42510DBF5
author name string	K L Lee E M Ohman K N Sigmon U Rosenschein
rdfs:label	Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (nl) Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials) (en)
skos:prefLabel	Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (nl) Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials) (en)
name	Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (nl) Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials) (en)
author	wds:Q56945551-1D19F6EB-8992-4DFA-8C67-558476BC6ABB wds:Q56945551-7146CBD5-5829-4100-8069-04734C387643 wds:Q56945551-89D43644-5ABB-4B98-8162-4F91BC01BD1B wds:Q56945551-CC6251AB-51D3-4472-A772-3EAA5D0E049D
author	Robert Califf Eric J. Topol Stephen G. Ellis A Michael Lincoff
title	wds:Q56945551-3D30663E-DD5B-4093-A08C-6B84D838D385
title	Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group (en)
page(s)	wds:Q56945551-7187EB18-44CE-4BCA-A7FC-01264ECDCE53
page(s)	871-876
instance of	wds:Q56945551-07C85501-8F88-47AA-8199-D1687632C585
instance of	scholarly article
main subject	wds:Q56945551-1CC6EFDF-5894-413C-9F2B-B0AD306295EC wds:Q56945551-2898C5D5-E344-4A47-A4C6-B86BFEC8CED5 wds:Q56945551-4C677115-6382-4517-B0E3-0379A632FA9A
main subject	myocardial infarction thrombolysis angioplasty
PubMed ID	wds:Q56945551-B8A34D17-2502-4400-902A-E5A2746E4D4D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7732992
PubMed ID	7732992
published in	wds:Q56945551-BEA73524-2D19-4001-8BCD-4ABC1EB94990
published in	American Journal of Cardiology
issue	wds:Q56945551-D59A5BB6-4AE2-4C11-B101-A2C2B7CE70AC
volume	wds:Q56945551-65E15DC8-C274-456E-84E9-EFC639319027
issue	14
volume	75
DOI	wds:Q56945551-68310E26-04B8-49DB-85A3-9D15F999E0E0
DOI	http://dx.doi.org/10.1016/S0002-9149(99)80678-X
DOI	10.1016/S0002-9149(99)80678-X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56945551
is cites work of	ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Ang Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Trial Time to Treatment: A Crucial Factor in Thrombolysis and Primary Angioplasty. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction Reperfusion revisited: beyond TIMI 3 flow. Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software